Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  502 نتائج ل ""Antiprotozoal Agents""

فلترة النتائج

Subject : leishmaniasis, cutaneous
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A phase Ib/II clinical study to evaluate the safety and efficacy of topical Arnica tincture to treat non-complicated cutaneous leishmaniasis in Colombia.

  • Authors : Robledo SM; PECET-Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.; López L

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Arnica*/Arnica*/Arnica*/chemistry ; Antiprotozoal Agents*/Antiprotozoal Agents*/Antiprotozoal Agents*/adverse effects

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Aug 18; Vol. 19 (8), pp. e0013123. Date of Electronic Publication: 2025 Aug 18 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Topical AuNPs-Cys-Sm29 gel modulates the course of lesion development in experimental cutaneous leishmaniasis.

  • Authors : Viana SM; Instituto Gonçalo Moniz, FIOCRUZ, Salvador, Brazil.; Cardoso L

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/immunology ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/pathology

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Sep 22; Vol. 19 (9), pp. e0013510. Date of Electronic Publication: 2025 Sep 22 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Successful treatment of meglumine antimoniate in patient with cutaneous leishmaniasis with end-stage renal failure undergoing hemodialysis: a case report.

  • Authors : Arab H; Faculty of Medicine, Hama University, Granada, Hama, Syria.; Alsaffaf Y

Subjects: Meglumine Antimoniate*/Meglumine Antimoniate*/Meglumine Antimoniate*/therapeutic use ; Meglumine Antimoniate*/Meglumine Antimoniate*/Meglumine Antimoniate*/administration & dosage ; Kidney Failure, Chronic*/Kidney Failure, Chronic*/Kidney Failure, Chronic*/therapy

  • Source: Journal of medical case reports [J Med Case Rep] 2025 Jun 16; Vol. 19 (1), pp. 277. Date of Electronic Publication: 2025 Jun 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The synergistic anti-leishmanial effect of photodynamic therapy employing chemotherapy-mediated nanocomposites.

  • Authors : Molaakbari E; Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.; Khosravi A

Subjects: Photochemotherapy*/Photochemotherapy*/Photochemotherapy*/methods ; Nanocomposites*/Nanocomposites*/Nanocomposites*/chemistry ; Antiprotozoal Agents*/Antiprotozoal Agents*/Antiprotozoal Agents*/pharmacology

  • Source: Scientific reports [Sci Rep] 2025 May 10; Vol. 15 (1), pp. 16282. Date of Electronic Publication: 2025 May 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice.

  • Authors : Saberi M; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.; Latifi A

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/parasitology ; Epidermal Growth Factor*/Epidermal Growth Factor*/Epidermal Growth Factor*/administration & dosage

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Jan 14; Vol. 19 (1), pp. e0012765. Date of Electronic Publication: 2025 Jan 14 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Safety profile of miltefosine in the treatment of cutaneous leishmaniasis.

  • Authors : Ribeiro LR; Pesquisa Clínica e Políticas Públicas em Doenças Infecto-Parasitárias, Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.; Silva SN

Subjects: Phosphorylcholine*/Phosphorylcholine*/Phosphorylcholine*/analogs & derivatives ; Phosphorylcholine*/Phosphorylcholine*/Phosphorylcholine*/adverse effects ; Phosphorylcholine*/Phosphorylcholine*/Phosphorylcholine*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Dec 13; Vol. 19 (12), pp. e0315710. Date of Electronic Publication: 2024 Dec 13 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Hematological profile among cutaneous leishmaniasis patients before and after treatment with sodium stibogluconate in Diyala, Iraq.

  • Authors : Hassan GM; Department of Biology, College of Science, University of Baghdad, Al-Jaderiya Campus, Baghdad, Iraq.; Ali HZ

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/blood ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/epidemiology

  • Source: Journal of infection in developing countries [J Infect Dev Ctries] 2024 Nov 30; Vol. 18 (11), pp. 1772-1779. Date of Electronic Publication: 2024 Nov 30.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Ambiguities in cutaneous leishmaniasis classification and the need for consensus: Experience from Ethiopia.

  • Authors : van Henten S; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Diro E

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/classification ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/pathology

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Aug 22; Vol. 19 (8), pp. e0013458. Date of Electronic Publication: 2025 Aug 22 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Systematic suppression of Leishmania (Leishmania) amazonensis-mediated delayed-type hypersensitivity response in American cutaneous leishmaniasis.

  • Authors : Campos MB; Evandro Chagas Institute (Surveillance Secretary of Health and Environment, Ministry of Health), Ananindeua, Pará, Brazil.; Lima LVR

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/immunology ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/parasitology

  • Source: Parasites & vectors [Parasit Vectors] 2025 Aug 05; Vol. 18 (1), pp. 336. Date of Electronic Publication: 2025 Aug 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101462774 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-3305

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effects of Amphotericin B-Conjugated Functionalized Carbon Nanoparticles in the Treatment of Cutaneous Leishmaniasis.

  • Authors : Heidari-Kharaji M; Department of Veterinary Medicine and Surgery, University of Missouri, Columbia, Missouri, USA.; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Subjects: Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/drug therapy ; Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/Leishmaniasis, Cutaneous*/parasitology ; Mice, Inbred BALB C*

  • Source: Parasite immunology [Parasite Immunol] 2024 Oct; Vol. 46 (10), pp. e13068.Publisher: Wiley Country of Publication: England NLM ID: 7910948 Publication Model: Print Cited Medium: Internet ISSN: 1365-3024 (Electronic)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  502 نتائج ل ""Antiprotozoal Agents""